---
title: "Quinfamide - Amebiasis"
sidebar: mydoc_sidebar
permalink: db12780-mesh-d000562-1.html
toc: false 
---


Path ID: `DB12780_MESH_D000562_1`
{% include image.html url="images/db12780-mesh-d000562-1.png" file="db12780-mesh-d000562-1.png" alt="db12780-mesh-d000562-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C026546">MESH:C026546 </a> | quinfamide | Drug |
| <a href="https://identifiers.org/GO:0048870">GO:0048870 </a> | cell motility | BiologicalProcess |
| <a href="https://identifiers.org/taxonomy:5759">taxonomy:5759 </a> | Entamoeba histolytica | OrganismTaxon |
| <a href="https://identifiers.org/MESH:D000562">MESH:D000562 </a> | Amebiasis | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Quinfamide | NEGATIVELY REGULATES | Cell Motility |
| Cell Motility | IN TAXON | Entamoeba Histolytica |
| Entamoeba Histolytica | CAUSES | Amebiasis |
|---------|-----------|---------|

Comment: Quinfamide is under phase III trial for the treatment of Amoebiasis and Helminthiasis.

Reference: 
  - [https://go.drugbank.com/drugs/DB12780#mechanism-of-action](https://go.drugbank.com/drugs/DB12780#mechanism-of-action)
  - [https://drugs.ncats.io/drug/O1ZB1046R1](https://drugs.ncats.io/drug/O1ZB1046R1)
  - [https://en.wikipedia.org/wiki/Amoebiasis](https://en.wikipedia.org/wiki/Amoebiasis)
